Relatively low levels of RBM4 were noted in cancerous tissues compared to adjacent normal tissues which were dissected from non-small cell lung cancer (NSCLC) and breast cancer (BC) patients [95]. Here, RBM4 is linked to non-small cell lung carcinoma.